Clin2
NCT06632080Possibly a fitNot yet recruiting

Testing how a natural brain chemical causes headaches

Healthy Volunteers Only

Part of Pain clinical trials.

This study tests whether a natural chemical called substance P can trigger headaches in healthy people, to help researchers understand why some people get migraines. You'll receive an infusion and be monitored for any headache response — your participation could help improve future migraine treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
21 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You must weigh between 50 and 100 kg (about 110–220 lbs).
  • You must have no history of any recurrent headache disorder (like migraine or cluster headaches), except for occasional mild tension headaches.
  • No immediate family members (parents, siblings, children) with a history of recurrent headache disorders.
  • You must not have any heart, blood vessel, or lung disease, and no past moderate/severe traumatic brain injury.
  • No daily medication use (other than contraceptives) and no caffeine, nicotine, alcohol, or any headache in the 48 hours before your infusion visit.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06959004Recruiting
Does substance P trigger migraine attacks without aura?

This study tests whether a substance called substance P can cause migraine attacks in people who have migraine without aura. Results may help understand new ways to prevent or treat migraine.

Glostrup Municipality
NCT07340788Not yet recruiting
Testing a migraine trigger for people without aura

This study looks at whether a natural substance called amylin can trigger migraine attacks in people who get migraines without aura. If you join, you'll receive an infusion and be monitored to see if you get a migraine, which could help researchers understand migraine causes.

Glostrup Municipality
NCT07451769Recruiting
Testing a new drug target for migraine relief

This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.

Glostrup Municipality
NCT07021859Recruiting
Migraine with aura study using CGRP to trigger attacks

This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.

Glostrup Municipality
NCT07059546Recruiting
Studying sensitivity to adrenomedullin in chronic post-traumatic headache

This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.

Glostrup Municipality
NCT06464367Recruiting· Early Phase 1
Psilocybin study for migraine and healthy volunteers

This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.

West Haven, Connecticut

Hear when a new Healthy Volunteers Only trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.